127 Results for "

FAP

" in MedChemExpress (MCE) Product Catalog:
Products (127)

127 Results for "FAP" in MCE Product Catalog:

  • Targets Recommended:
42
42 Publications Verification
Cat. No.: HY-13233A
CAS No.: 150080-09-4
Purity:  98.35%
Synonyms: Val-boroPro mesylate; PT100 mesylate
Target:  

Dipeptidyl Peptidase

Research Areas:  

Inflammation/Immunology Cancer

Talabostat mesylate (Val-boroPro mesylate; PT100 mesylate) is an orally active and nonselective dipeptidyl peptidase IV (DPP-IV) inhibitor (IC50 < 4 nM; Ki = 0.18 nM) and the inhibitor of fibroblast activation protein (FAP) (IC50 = 560 nM), inhibits DPP8/9 (IC50 = 4/11 nM; Ki = 1.5/0.76 nM), quiescent cell proline dipeptidase (QPP) (IC50 = 310 nM), DPP2, and some other DASH family enzymes. Antineoplastic and hematopoiesis- stimulating activities .
32
32 Cited Publications
Cat. No.: HY-128643
CAS No.: 2374782-02-0
Purity:  98.29%
Target:  

FAP

Research Areas:  

Cancer

FAPI-4 is a potent fibroblast activation protein (FAP) inhibitor for the targeting FAP. FAPI-4 can be used in cancer research. 68Ga-FAPI-4 PET/CT is a promising new diagnostic method for imaging various kinds of cancer, with good tumor-to-background contrast ratios .
7
7 Cited Publications
Cat. No.: HY-147057
CAS No.: 2581741-18-4
Purity:  99.54%
Synonyms: FAP-2286
Target:  

FAP

Research Areas:  

Cancer

Rofapitide tetraxetan (FAP-2286) is a potent and selective FAP-binding peptide with a mean IC50 value of 2.7 nM for binding to FAP. Rofapitide tetraxetan can be labeled with radionuclides for diagnostic applications. Rofapitide tetraxetan has antitumor activity .
5
5 Cited Publications
Cat. No.: HY-101801
CAS No.: 886992-99-0
Purity:  ≥98.0%
Target:  

FAP

Research Areas:  

Cancer

Ac-Gly-BoroPro is a selective FAP inhibitor with a Ki of 23 nM.
3
3 Cited Publications
Cat. No.: HY-137331
CAS No.: 2374782-04-2
Purity:  98.57%
Target:  

FAP

Research Areas:  

Cancer

FAPI-46 is a quinoline-based fibroblast activation protein (FAP)-targeted tracer. Use radioactivity FAPI-46 labeled with 68Ga or 177Lu can be used for tumor imaging in a variety of cancers and has higher tumor uptake rates and longer tumor accumulation .
2
2 Cited Publications
Cat. No.: HY-P72659A
Purity:  ≥ 95%, as determined by reducing SDS-PAGE.
Synonyms: Prolyl endopeptidase FAP; FAP; FAPA; DPPIV; SIMP; FAPalpha
Species:  
Source:  
2
2 Cited Publications
Cat. No.: HY-100684
CAS No.: 1448440-52-5
Purity:  99.51%
Research Areas:  

Cancer

UAMC-1110 is a highly potent and selective inhibitor of fibroblast activation protein (FAP) with an IC50 of 3.2 nM. UAMC-1110 also inhibits prolyl oligopeptidase (PREP) with an IC50 of 1.8 μM .
1
1 Cited Publications
Cat. No.: HY-P99269
CAS No.: 216669-97-5
Synonyms: BIBH 1; Anti-Human FAP Recombinant Antibody

Target:  

FAP

Research Areas:  

Cancer

Sibrotuzumab (BIBH 1) is a humanized IgG1 monoclonal antibody targets fibroblast activation protein (FAP). Sibrotuzumab can be used for the research of colorectal cancer and non-small cell lung cancer (NSCLC) .
1
1 Cited Publications
Cat. No.: HY-W010991
CAS No.: 64967-39-1
Synonyms: FAPGG
Research Areas:  

Others

N-[3-(2-Furyl)acryloyl]-Phe-Gly-Gly (FAPGG) is a specific substrate of angiotensin converting enzyme (ACE) with a Ki of 2.546×10 -4 M. It is used as a chromogenic probe for quantitative detection of ACE activity. N-[3-(2-Furyl)acryloyl]-Phe-Gly-Gly can be hydrolyzed by ACE to generate N-[3-(2-furyl)acryloyl]-Phe (FAP) and Gly-Gly, and the ACE inhibitory effect is monitored by photometry. FAPGG competitively binds to the active center of ACE and is a key tool for screening ACE inhibitors such as Captopril (HY-B0368) and Dioscorin. Its reversible mechanism of action supports hypertension research and drug development targeting the renin-angiotensin system .
1
1 Cited Publications
Cat. No.: HY-47979
CAS No.: 2471983-20-5
Target:  

FAP

Research Areas:  

Cancer

FAP-IN-2 is an isonitrile-containing fibroblast activation protein (FAP) inhibitor. FAP-IN-2 can be labeled with technetium-99m ( 99mTc) for targeted tumor SPECT imaging .
1
1 Cited Publications
Cat. No.: HY-145983
CAS No.: 80049-85-0
Purity:  99.16%
Research Areas:  

Cancer

Suc-Gly-Pro-AMC is a fluorescent substrate. Suc-Gly-Pro-AMC is a fibroblast activation protein (FAP) specific substrate. Suc-Gly-Pro-AMC reacts with recombinant porcine prolyl oligopeptidase. Suc-Gly-Pro-AMC can be used to study the activity of FAP, prolyl endopeptidase (PREP). Suc-Gly-Pro-AMC is used in glioma research .
1
1 Cited Publications
Cat. No.: HY-47979A
Target:  

FAP

Research Areas:  

Cancer

FAP-IN-2 TFA is an isonitrile-containing fibroblast activation protein (FAP) inhibitor. FAP-IN-2 TFA can be labeled with technetium-99m ( 99mTc) for targeted tumor SPECT imaging .
1
1 Cited Publications
Cat. No.: HY-P77934
Purity:  ≥ 95%, as determined by reducing SDS-PAGE or Bis-Tris PAGE.
Synonyms: FAP; FAPalpha; SIMP; Seprase; APCE; DPPIV; DPPIVA; FAPA
Species:  
Source:  
Cat. No.: HY-147173
CAS No.: 2374782-76-8
Purity:  99.82%
Target:  

FAP

Research Areas:  

Cancer

FAPI-74 is a PET (positron emission tomography) tracer targeting the fibroblast activation protein (FAP). FAPI-74 can be used for FAP-positive tumor research .
Cat. No.: HY-164316
CAS No.: 2883407-81-4
Target:  

FAP

Research Areas:  

Others

FT-FAPI-12_9 is a FAP ligand that can be used to synthesize FAPI-46, a radiotracer targeting FAP .
Cat. No.: HY-172317
CAS No.: 2791472-12-1
Target:  

FAP

Research Areas:  

Metabolic Disease

AZD2389 is a potent and orally active FAP inhibitor. AZD2389 can be used for the study of metabolic dysfunction-associated steatohepatitis .
Cat. No.: HY-P10944
CAS No.: 3076330-05-4
Synonyms: NNS309
Target:  

FAP

Research Areas:  

Inflammation/Immunology Cancer

Unlabeled FXX489 (NNS309) is a fibroblast activation protein (FAP)-targeting ligand. Unlabeled FXX489 can be labeled with 68Ga and 177Lu and shows anticancer effects. Unlabeled FXX489 can be used for the study of pancreatic ductal adenocarcinoma (PDAC), non-small cell lung cancer (NSCLC), breast cancer (BC), and colorectal cancer (CRC) .
Cat. No.: HY-136641
CAS No.: 2374782-03-1
Purity:  99.26%
Research Areas:  

Cancer

NOTA-FAPI is a fibroblast activation protein (FAP) inhibitor. NOTA-FAPI can be used as a probe for FAP-targeted tumour imaging. NOTA-FAPI has good tumour detection efficacy and excellent imaging quality .
Cat. No.: HY-145938
CAS No.: 2639365-69-6
Purity:  99.77%
Target:  

FAP

Research Areas:  

Cancer

OncoFAP is an ultra-high-affinity ligand of fibroblast activation protein (FAP) for targeting applications with pan-tumoral potential.
Cat. No.: HY-P10945
CAS No.: 3076328-74-7
Research Areas:  

Cancer

FAP targeting peptide for FXX489 is the polypeptide part of Unlabeled FXX489 (HY-P10944). Unlabeled FXX489 is a fibroblast activation protein (FAP)-targeting ligand .